Boehringer Ingelheim India MD Sharad Tyagi has been appointed as the new president of Organisation of Pharmaceutical Producers of India (OPPI).
A statement released from OPPI said that Tyagi has been given reins for three years with effect from April 01, 2020.
He will be replacing A Vaidheesh, Managing Director, India, Glaxo SmithKline Pharmaceuticals Ltd.
Tyagi has been a Vice President and Executive Committee of OPPI for the last ten years, heading important work groups and committees for the organisation, it added.
Also read: R Ananthanarayanan appointed as CEO, MD of Strides
“I welcome Sharad as the new President and under his leadership, I am confident that OPPI will continue to advocate for patient-centred policies that are focused towards building a healthier India through access to innovation,” Vaidheesh said.
Established in 1965, OPPI represents the research-based pharmaceutical companies in India.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
